ARCA biopharma, Inc. (ABIO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 47.15M |
| Enterprise value | 11.25M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.34 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.43 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.21 |
| 52-week change 3 | 56.25% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 3.8800 |
| 52-week low 3 | 1.5600 |
| 50-day moving average 3 | 2.3700 |
| 200-day moving average 3 | 2.0003 |
Share statistics
| Avg vol (3-month) 3 | 1.48M |
| Avg vol (10-day) 3 | 248.78k |
| Shares outstanding 5 | 14.51M |
| Implied shares outstanding 6 | 14.51M |
| Float 8 | 5.68M |
| % held by insiders 1 | 1.29% |
| % held by institutions 1 | 76.97% |
| Shares short (15 Apr 2024) 4 | 5.66M |
| Short ratio (15 Apr 2024) 4 | 1.37 |
| Short % of float (15 Apr 2024) 4 | 54.63% |
| Short % of shares outstanding (15 Apr 2024) 4 | 39.05% |
| Shares short (prior month 15 Mar 2024) 4 | 183.58k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 04 Apr 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:18 |
| Last split date 3 | 04 Apr 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -12.42% |
| Return on equity (ttm) | -15.87% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -7.81M |
| Net income avi to common (ttm) | -6M |
| Diluted EPS (ttm) | -0.4200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 37.43M |
| Total cash per share (mrq) | 2.58 |
| Total debt (mrq) | 280k |
| Total debt/equity (mrq) | 0.76% |
| Current ratio (mrq) | 23.19 |
| Book value per share (mrq) | 2.55 |
Cash flow statement
| Operating cash flow (ttm) | -4.95M |
| Levered free cash flow (ttm) | -3.61M |
© 2024 Yahoo. All rights reserved.